Skip to main content
Have a personal or library account? Click to login
Role of Artificial Intelligence and Machine Learning to Create Predictors, Enhance Molecular Understanding, and Implement Purposeful Programs for Myocardial Recovery Cover

Role of Artificial Intelligence and Machine Learning to Create Predictors, Enhance Molecular Understanding, and Implement Purposeful Programs for Myocardial Recovery

Open Access
|Aug 2024

References

  1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the Management of Heart Failure: A report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062
  2. Katz AM. The “modern” view of heart failure. Circ Heart Fail. 2008 May;1(1):63-71. doi: 10.1161/CIRCHEARTFAILURE.108.772756
  3. Roger VL. Epidemiology of heart failure: A contemporary perspective. Circ Res. 2021 May 14;128(10):1421-34. doi: 10.1161/CIRCRESAHA.121.318172
  4. Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failing heart. J Am Coll Cardiol. 2012 Dec 18;60(24):2465-72. doi: 10.1016/j.jacc.2012.06.062
  5. Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart failure with recovered left ventricular ejection fraction. J Am Coll Cardiol. 2020 Aug;76(6):719-34. doi: 10.1016/j.jacc.2020.05.075
  6. Florea VG, Rector TS, Anand IS, Cohn JN. Heart failure with improved ejection fraction: Clinical characteristics, correlates of recovery, and survival. Circ Heart Fail. 2016 Jul;9(7). doi: 10.1161/CIRCHEARTFAILURE.116.003123
  7. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, et al. Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction. JAMA Cardiol. 2016 Aug 1;1(5):510. doi: 10.1001/jamacardio.2016.1325
  8. Quer G, Arnaout R, Henne M, Arnaout R. Machine learning and the future of cardiovascular care: JACC state-of-the-art review. J Am Coll Cardiol. 2021 Jan 26;77(3):300-13. doi: 10.1016/j.jacc.2020.11.030
  9. Averbuch T, Sullivan K, Sauer A, Mamas MA, Voors AA, Gale CP, et al. Applications of artificial intelligence and machine learning in heart failure. Eur Heart J Digit Health. 2022 Jul 6;3(2):311-22. doi: 10.1093/ehjdh/ztac025
  10. Armoundas AA, Narayan SM, Arnett DK, et al. Use of artificial intelligence in improving outcomes in heart disease: A scientific statement from the American Heart Association. Circulation. 2024 Feb 28;149(14):e1028-e1050. doi: 10.1161/CIR.0000000000001201
  11. Khan MS, Arshad MS, Greene SJ, et al. Artificial intelligence and heart failure: A state-of-the-art review. Eur J Heart Fail. 2023 Sep;25(9):1507-25. doi: 10.1002/ejhf.2994
  12. Kwon JM, Kim KH, Jeon KH, et al. Development and validation of deep-learning algorithm for electrocardiography-based heart failure identification. Korean Circ J. 2019 Jul;49(7):629-39. doi: 10.4070/kcj.2018.0446
  13. Attia ZI, Kapa S, Lopez-Jimenez F, et al. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat Med. 2019 Jan;25(1):70-4. doi: 10.1038/s41591-018-0240-2
  14. Choi DJ, Park JJ, Ali T, Lee S. Artificial intelligence for the diagnosis of heart failure. NPJ Digit Med. 2020 Apr 8;3(1):54. doi: 10.1038/s41746-020-0261-3
  15. Wu J, Biswas D, Ryan M, et al. Artificial intelligence methods for improved detection of undiagnosed heart failure with preserved ejection fraction. Eur J Heart Fail. 2024 Jan 11;26:302-310. doi: 10.1002/ejhf.3115
  16. Bhave S, Rodriguez V, Poterucha T, et al. Deep learning to detect left ventricular structural abnormalities in chest X-rays. Eur Heart J. 2024 Mar 20;ehad782. doi: 10.1093/eurheartj/ehad782
  17. Motwani M, Dey D, Berman DS, et al. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. Eur Heart J. 2016 Jun 1;ehw188. doi: 10.1093/eurheartj/ehw188
  18. Zhao J, Feng Q, Wu P, et al. Learning from longitudinal data in electronic health record and genetic data to improve cardiovascular event prediction. Sci Rep. 2019 Jan 24;9(1):1-10. doi: 10.1038/s41598-018-36745-x
  19. Kwon JM, Kim KH, Jeon KH, et al. Artificial intelligence algorithm for predicting mortality of patients with acute heart failure. PLoS One. 2019 Jul 8;14(7):e0219302. doi: 10.1371/journal.pone.0219302
  20. Angraal S, Mortazavi BJ, Gupta A, et al. Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction. JACC Heart Fail. 2020 Jan;8(1):12-21. doi: 10.1016/j.jchf.2019.06.013
  21. Adler ED, Voors AA, Klein L, et al. Improving risk prediction in heart failure using machine learning. Eur J Heart Fail. 2020 Jan;22(1):139-47. doi: 10.1002/ejhf.1628
  22. Segar MW, Jaeger BC, Patel KV, et al. Development and validation of machine learning-based race-specific models to predict 10-year risk of heart failure: A multicohort analysis. Circulation. 2021 Jun 15;143(24):2370-83. doi: 10.1161/CIRCULATIONAHA.120.053134
  23. Raghunath S, Pfeifer JM, Ulloa-Cerna AE, et al. Deep neural networks can predict new-onset atrial fibrillation from the 12-lead ECG and help identify those at risk of atrial fibrillation-related stroke. Circulation. 2021 Mar 30;143(13):1287-98. doi: 10.1161/CIRCULATIONAHA.120.047829
  24. Miller T, Lang FM, Rahbari A, Theodoropoulos K, Topkara VK. Right heart failure after durable left ventricular assist device implantation. Expert Rev Med Devices. 2024 Mar 3;21(3):197-206. doi: 10.1080/17434440.2024.2305362
  25. Shah SJ, Katz DH, Selvaraj S, et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015 Jan 20;131(3):269-79. doi: 10.1161/CIRCULATIONAHA.114.010637
  26. Gevaert AB, Tibebu S, Mamas MA, et al. Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes. ESC Heart Fail. 2021 Aug;8(4):2741-54. doi: 10.1002/ehf2.13344
  27. Tayal U, Verdonschot JAJ, Hazebroek MR, et al. Precision phenotyping of dilated cardiomyopathy using multidimensional data. J Am Coll Cardiol. 2022 Jun 7;79(22):2219-32. doi: 10.1016/j.jacc.2022.03.375
  28. Ahmad T, Lund LH, Rao P, et al. Machine learning methods improve prognostication, identify clinically distinct phenotypes, and detect heterogeneity in response to therapy in a large cohort of heart failure patients. J Am Heart Assoc. 2018 Apr 12;7(8). doi: 10.1161/JAHA.117.008081
  29. Karwath A, Bunting KV, Gill SK, et al. Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis. Lancet. 2021 Oct 16;398(10309):1427-35. doi: 10.1016/S0140-6736(21)01638-X
  30. Gu J, Pan JA, Lin H, Zhang JF, Wang CQ. Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction. Int J Cardiol. 2021 Jan;323:148-54. doi: 10.1016/j.ijcard.2020.08.065
  31. Kresoja KP, Unterhuber M, Wachter R, et al. Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials. EBioMedicine. 2023 Oct;96(104795):104795. doi: 10.1016/j.ebiom.2023.104795
  32. Tison GH, Sanchez JM, Ballinger B, et al. Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiol. 2018 May 1;3(5):409. doi: 10.1001/jamacardio.2018.0136
  33. Muralitharan S, Nelson W, Di S, et al. Machine learning-based early warning systems for clinical deterioration: Systematic scoping review. J Med Internet Res. 2021 Feb 4;23(2):e25187. doi: 10.2196/25187
  34. Hannun AY, Rajpurkar P, Haghpanahi M, et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019 Jan;25(1):65-9. doi: 10.1038/s41591-018-0268-3
  35. Ribeiro AH, Ribeiro MH, Paixão GMM, et al. Automatic diagnosis of the 12-lead ECG using a deep neural network. Nat Commun. 2020 Apr 9;11(1):1760. doi: 10.1038/s41467-020-15432-4
  36. Olaisen S, Smistad E, Espeland T, et al. Automatic measurements of left ventricular volumes and ejection fraction by artificial intelligence: clinical validation in real time and large databases. Eur Heart J Cardiovasc Imaging. 2024 Feb 22;25(3):383-95. doi: 10.1093/ehjci/jead280
  37. Carluccio E, Biagioli P, Reboldi G, et al. Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies. Cardiovasc Diabetol. 2023 Sep 2;22(1). doi: 10.1186/s12933-023-01970-w
  38. Itagaki S, Moss N, Toyoda N, et al. Incidence, outcomes, and opportunity for left ventricular assist device weaning for myocardial recovery. JACC Heart Fail. 2024 Jan;12(5):893-901. doi: 10.1016/j.jchf.2023.12.006
  39. Birks EJ, Drakos SG, Patel SR, et al. Prospective multicenter study of myocardial recovery using left ventricular assist devices (RESTAGE-HF [remission from Stage D Heart Failure]). Circulation. 2020 Nov 24;142(21):2016-28. doi: 10.1161/CIRCULATIONAHA.120.046415
  40. Kramer DG, Trikalinos TA, Kent DM, Antonopoulos GV, Konstam MA, Udelson JE. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol. 2010 Jul 27;56(5):392-406. doi: 10.1016/j.jacc.2010.05.011
  41. Dandel M, Weng Y, Siniawski H, et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation. 2008 Sep 30;118(14 Suppl):S94-105. doi: 10.1161/CIRCULATIONAHA.107.755983
  42. Birks EJ, George RS, Firouzi A, et al. Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. J Thorac Cardiovasc Surg. 2012 Jul;144(1):190-6. doi: 10.1016/j.jtcvs.2012.03.021
  43. Wilcox JE, Fonarow GC, Yancy CW, et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012 Jan;163(1):49-56.e2. doi: 10.1016/j.ahj.2011.10.001
  44. Basuray A, French B, Ky B, et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation. 2014 Jun 10;129(23):2380-7. doi: 10.1161/CIRCULATIONAHA.113.006855
  45. Lupón J, Díez-López C, de Antonio M, et al. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Eur J Heart Fail. 2017 Dec;19(12):1615-23. doi: 10.1002/ejhf.824
  46. Ghimire A, Fine N, Ezekowitz JA, Howlett J, Youngson E, McAlister FA. Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study. Eur Heart J. 2019 Jul 1;40(26):2110-7. doi: 10.1093/eurheartj/ehz233
  47. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005 Aug 30;112(9 Suppl):I32-6. doi: 10.1161/CIRCULATIONAHA.104.524124
  48. Goldstein DJ, Maybaum S, MacGillivray TE, et al. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. J Card Fail. 2012 May;18(5):392-5. doi: 10.1016/j.cardfail.2012.01.020
  49. Wever-Pinzon O, Drakos SG, McKellar SH, et al. Cardiac recovery during long-term left ventricular assist device support. J Am Coll Cardiol. 2016 Oct;68(14):1540-53. doi: 10.1016/j.jacc.2016.07.743
  50. Topkara VK, Garan AR, Fine B, et al. Myocardial recovery in patients receiving contemporary left ventricular assist devices. Circ Heart Fail. 2016 Jul;9(7). doi: 10.1161/CIRCHEARTFAILURE.116.003157
  51. Birks EJ. Another grain in the search for the true rate of myocardial recovery. J Am Coll Cardiol. 2016 Oct;68(14):1554-6. doi: 10.1016/j.jacc.2016.07.742
  52. Cikes M, Sanchez-Martinez S, Claggett B, et al. Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy. Eur J Heart Fail. 2019 Jan;21(1):74-85. doi: 10.1002/ejhf.1333
  53. Howell SJ, Stivland T, Stein K, Ellenbogen KA, Tereshchenko LG. Using machine-learning for prediction of the response to cardiac resynchronization therapy. JACC Clin Electrophysiol. 2021 Dec;7(12):1505-15. doi: 10.1016/j.jacep.2021.06.009
  54. Gallard A, Bidaut A, Hubert A, et al. Characterization of responder profiles for cardiac resynchronization therapy through unsupervised clustering of clinical and strain data. J Am Soc Echocardiogr. 2021 May;34(5):483-93. doi: 10.1016/j.echo.2021.01.019
  55. Hubert A, Gallard A, Rolle VL, et al. Left ventricular strain for predicting the response to cardiac resynchronization therapy: two methods for one question. Eur Heart J Cardiovasc Imaging. 2021 Jan 31;22(12):1482-1489. doi: 10.1093/ehjci/jeaa422
  56. de A. Fernandes F, Larsen K, He Z, et al. A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support. Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3022-33. doi: 10.1007/s00259-023-06259-4
  57. Bivona DJ, Tallavajhala S, Abdi M, et al. Machine learning for multidimensional response and survival after cardiac resynchronization therapy using features from cardiac magnetic resonance. Heart Rhythm O2. 2022 Oct;3(5):542-52. doi: 10.1016/j.hroo.2022.06.005
  58. Haque A, Stubbs D, Hubig NC, Spinale FG, Richardson WJ. Interpretable machine learning predicts cardiac resynchronization therapy responses from personalized biochemical and biomechanical features. BMC Med Inform Decis Mak. 2022 Oct 31;22(1):282. doi: 10.1186/s12911-022-02015-0
  59. He Z, Zhang X, Zhao C, et al. A method using deep learning to discover new predictors from left-ventricular mechanical dyssynchrony for CRT response. J Nucl Cardiol. 2023 Feb;30(1):201-13. doi: 10.1007/s12350-022-03067-5
  60. MacGregor RM, Guo A, Masood MF, et al. Machine learning outcome prediction in dilated cardiomyopathy using regional left ventricular multiparametric strain. Ann Biomed Eng. 2021 Feb;49(2):922-32. doi: 10.1007/s10439-020-02639-1
  61. Mohebi R, Liu Y, Felker GM, et al. Prediction of left ventricular ejection fraction change following treatment with sacubitril/valsartan. JACC Heart Fail. 2023 Jan;11(1):44-54. doi: 10.1016/j.jchf.2022.09.009
  62. Mele M, Imbrici P, Mele A, et al. Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach. Front Pharmacol. 2023 Jun 9:14:1175606. doi: 10.3389/fphar.2023.1175606
  63. Topkara VK, Elias P, Jain R, Sayer G, Burkhoff D, Uriel N. Machine learning-based prediction of myocardial recovery in patients with left ventricular assist device support. Circ Heart Fail. 2022 Jan;15(1):e008711. doi: 10.1161/CIRCHEARTFAILURE.121.008711
  64. Adekkanattu P, Rasmussen LV, Pacheco JA, et al. Prediction of left ventricular ejection fraction changes in heart failure patients using machine learning and electronic health records: a multi-site study. Sci Rep. 2023 Jan 6;13:294. doi: 10.1038/s41598-023-27493-8
  65. Gaggin HK, Szymonifka J, Bhardwaj A, et al. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure. JACC Heart Fail. 2014 Feb;2(1):65-72. doi: 10.1016/j.jchf.2013.10.005
  66. Motiwala SR, Szymonifka J, Belcher A, et al. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail. 2013 Oct;15(10):1157-63. doi: 10.1093/eurjhf/hft075
  67. Ravassa S, Lupón J, López B, et al. Prediction of left ventricular reverse remodeling and outcomes by circulating collagen-derived peptides. JACC Heart Fail. 2023 Jan;11(1):58-72. doi: 10.1016/j.jchf.2022.09.008
  68. Diakos NA, Taleb I, Kyriakopoulos CP, et al. Circulating and myocardial cytokines predict cardiac structural and functional improvement in patients with heart failure undergoing mechanical circulatory support. J Am Heart Assoc. 2021 Oct 19;10(20):e020238. doi: 10.1161/JAHA.120.020238
  69. Yang KC, Yamada KA, Patel AY, et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014 Mar 4;129(9):1009-21. doi: 10.1161/CIRCULATIONAHA.113.003863
  70. Ton VK, Vunjak-Novakovic G, Topkara VK. Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature. Expert Rev Med Devices. 2016 Nov;13(11):1029-34. doi: 10.1080/17434440.2016.1243053
  71. Topkara VK, Chambers KT, Yang KC, et al. Functional significance of the discordance between transcriptional profile and left ventricular structure/function during reverse remodeling. JCI Insight. 2016 Apr;1(4). doi: 10.1172/jci.insight.86038
  72. Kim GH, Uriel N, Burkhoff D. Reverse remodelling and myocardial recovery in heart failure. Nat Rev Cardiol. 2018 Feb;15(2):83-96. doi: 10.1038/nrcardio.2017.139
  73. Liao X, Kennel PJ, Liu B, et al. Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heart. JCI Insight. 2023 Feb 22;8(4). doi: 10.1172/jci.insight.161788
  74. Drakos SG, Badolia R, Makaju A, et al. Distinct transcriptomic and proteomic profile specifies patients who have Heart Failure with potential of myocardial recovery on mechanical unloading and circulatory support. Circulation. 2023 Jan 31;147(5):409-24. doi: 10.1161/CIRCULATIONAHA.121.056600
  75. Ouwerkerk W, Belo Pereira JP, Maasland T, et al. Multiomics analysis provides novel pathways related to progression of heart failure. J Am Coll Cardiol. 2023 Nov 14;82(20):1921-31. doi: 10.1016/j.jacc.2023.08.053
  76. de Bakker M, Petersen TB, Rueten-Budde AJ, et al. Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure. Eur Heart J Digit Health. 2023 Dec 1;4(6):444-54. doi: 10.1093/ehjdh/ztad056
  77. Wehbe RM. Unleashing the power of machine learning to predict myocardial recovery after left ventricular assist device: A call for the inclusion of unstructured data sources in heart failure registries. Circ Heart Fail. 2022 Jan;15(1). doi: 10.1161/CIRCHEARTFAILURE.121.009278
  78. Davies DR, Redfield MM, Scott CG, et al. A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction. JAMA Cardiol. 2022 Oct 1;7(10):1036. doi: 10.1001/jamacardio.2022.1781
  79. Kawamoto K, Finkelstein J, Del Fiol G. Implementing machine learning in the electronic health record: Checklist of essential considerations. Mayo Clin Proc. 2023 Mar;98(3):366-9. doi: 10.1016/j.mayocp.2023.01.013
  80. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-726. doi: 10.1093/eurheartj/ehab368
DOI: https://doi.org/10.14797/mdcvj.1392 | Journal eISSN: 1947-6108
Language: English
Page range: 76 - 87
Submitted on: Apr 10, 2024
Accepted on: May 23, 2024
Published on: Aug 20, 2024
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2024 Frederick M. Lang, Benjamin C. Lee, Dor Lotan, Mert. R. Sabuncu, Veli K. Topkara, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.